Keiretsu Forum Global Investor Network Achieved 380+ Company Fundings in 2021

Deal activity increases 20+%. Once again Life Science/Med Tech was the sector leader, with Technology and Fintech investments showing the largest increase on a percentage basis

SAN FRANCISCO, CA—Keiretsu Forum, the world’s largest angel investor network and ranked by Pitchbook as one of the “Most active investors early stage” and “Most active investors late stage,” announced it achieved a record 380+ fundings into seed, early-stage, and late-stage companies in 2021. Despite the global challenges, Keiretsu Forum saw deal activity increase 20+% compared to 2020, with Life Science/MedTech, Fintech, and Technology attracting the most capital.

“Keiretsu Forum continues to grow across North America and globally. Investors and entrepreneurs are benefiting from our unique footprint, disciplined process for originating quality deal flow and success syndicating early and late-stage investment opportunities,” said Randy Williams, Keiretsu Forum Founder and CEO. “We continue to welcome expanded partnerships to benefit the Keiretsu Forum Network community. Despite the global disruptions, we are likely to see continued growth across all sectors in 2022,” continued Williams.

2021 Keiretsu Forum members backed companies receiving significant funding included:

  • Soteria Battery
  • Orion Biotechnology
  • Epilogue Systems
  • Inmedix
  • MAIA Biotech
  • E2C Technology
  • DigitSec
  • Alga Energy
  • AI Optics
  • Lumoptik
  • Light Line Medical
  • NexGel
  • Maxwell Biosciences
  • KitoTech Medical
  • OtoNexus Medical Technologies
  • Seneca Therapeutics
  • Key Co
  • Joule Case